Clinical trials
Completed Hypertension trials in Singapore
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 2 |
| 2009 | 3 |
| 2011 | 2 |
| 2012 | 1 |
| 2014 | 2 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis | 4 |
| Changi General Hospital | 2 |
| Novartis Pharmaceuticals | 2 |
| Sanofi | 2 |
| CSL Behring | 1 |
| Daniel Benjamin | 1 |
| Duke-NUS Graduate Medical School | 1 |
| Eli Lilly and Company | 1 |
| GlaxoSmithKline | 1 |
| National Heart Centre Singapore | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension | 22 |
| Cardiovascular Diseases | 6 |
| Stroke | 4 |
| Diabetes Mellitus | 3 |
| Hyperaldosteronism | 3 |
| Arrhythmias, Cardiac | 2 |
| Dyslipidemias | 2 |
| Heart Diseases | 2 |
| Heart Failure | 2 |
| Hyperlipidemias | 2 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.